
Loading, please wait...

Loading, please wait...

Chagas disease (CD) significantly impacts gastrointestinal health, often leading to severe esophageal dysfunction. Recent research highlights how the latest diagnostic standards clarify esophageal motility in Chagas patients. By applying the Chicago Classification v4.0 (CCv4.0), clinicians can now better categorize the complex motor patterns observed in this population. This update is vital for gastroenterologists who manage esophageal disorders in endemic and non-endemic regions alike.
The study analyzed 129 patients with positive serology for Chagas disease to determine the prevalence of various motor disorders. Interestingly, achalasia emerged as the most frequent diagnosis, appearing in over 32% of the entire cohort. Additionally, researchers identified absent contractility and ineffective esophageal motility in a substantial number of subjects. Furthermore, the source of patient referral played a critical role in the diagnostic profile observed. For instance, among patients with obstructive symptoms, the prevalence of achalasia reached 44%.
While achalasia remains a hallmark of the condition, nearly a quarter of the patients showed normal manometry results. This finding suggests that symptoms do not always correlate with severe manometric abnormalities. Moreover, the inclusion of multiple rapid swallows (MRS) provided deeper insights into motor responses. Consequently, this study offers a clearer framework for understanding the spectrum of esophageal dismotility. Therefore, applying CCv4.0 helps bridge the gap in knowledge created by earlier, less standardized classification systems.
The application of CCv4.0 provides a standardized approach to diagnosing esophageal issues in Chagas disease. It highlights the high prevalence of achalasia while acknowledging the presence of hypocontractile patterns. Physicians should consider these variations when managing patients with suspected esophageal involvement. Because diagnostic profiles vary by referral source, a tailored approach to high-resolution esophageal manometry is essential for accurate clinical management.
According to recent studies using CCv4.0, achalasia is the most frequent pattern, identified in approximately 32.6% of all Chagas disease patients and 44% of those with obstructive symptoms.
No, research indicates that about 23.2% of patients with Chagas disease may still show normal esophageal motility on high-resolution manometry despite having the infection.
The study found that diagnostic profiles varied significantly based on where patients were referred from, which helps explain the discrepancies found in older esophageal motility research.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Mendonça FN et al. The Spectrum of Esophageal Dismotility in Chagas Disease on High-Resolution Esophageal Manometry As Defined By Chicago Classification V4.0. J Clin Gastroenterol. 2026 May 22. doi: 10.1097/MCG.0000000000002401. PMID: 42172050.
Yadlapati R, et al. Esophageal motility classification: Chicago Classification version 4.0. Neurogastroenterol Motil. 2021;33(1):e14058.
de Oliveira RB, et al. Gastrointestinal manifestations of Chagas disease. Am J Trop Med Hyg. 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study applies Chicago Classification v4.0 to Chagas disease, identifying achalasia in nearly half of symptomatic patients and clarifying motor pattern...
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today